Identification of IL6R and chromosome 11q13.5 as risk loci for asthma
Manuel AR Ferreira, Melanie C Matheson, David L Duffy, Guy B Marks, Jennie Hui, Peter Le Souef, Patrick Danoy, Svetlana Baltic, Dale R Nyholt, Mark Jenkins, Catherine Hayden, Gonneke Willemsen, Wei Ang, Mikko Kuokkanen, John Beilby, Faang Cheah, Eco JC de Geus, Adaikalavan Ramasamy, Sailaja Vedantam, Veikko Salomaa Show all
The Lancet | ELSEVIER SCIENCE INC | Published : 2011
Awarded by Australian National Health and Medical Research Council
Awarded by Medical Research Council
MAF owns stock in Illumina, Roche, and Complete Genomics. PST's institution has received consulting fees from GlaxoSmithKline as a result of activities outside this work. PST has received lecture fees from GlaxoSmithKline and Novartis. GTO has received consulting fees from Novartis and Sunovion Inc, as a result of work unrelated to this study. G BM was a board member of Novartis; GBM's institution received fees for lectures and preparation of educational presentations from Boehringer Ingelheim and AstraZeneca. CFR received consulting fees from GlaxoSmithKline and Merck as a result of activities outside this work. ASK's institution received speaker's fees from Nutricia. All other authors declare that they have no conflicts of interest.The Australian Asthma Genetics Consortium was supported by the Australian National Health and Medical Research Council (613627). Detailed acknowledgments and funding sources are provided in the webappendix (pp 27-30).